← All indications
Antithrombins
Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins.
Subtype terms (1)
More specific conditions that are subtypes of Antithrombins in the MeSH hierarchy.
Drugs by status
Phase 4 trials (4)
Phase 3 trials (1)
Phase 2 trials (3)
Other trials (1)